芯成科技(00365.HK)擬進一步拓展鳥情監控領域業務
芯成科技(00365.HK)公布,今年與梅林泰特設立合營公司芯泰智能科技,並增設轄下附屬芯泰智能廣東,主要從事先進國產雷達硬件研發製造與智能軟件發展、應用和系統集成,面向全球提供探鳥雷達設備、配套技術和場景應用軟件及系統。
公司透露,芯泰智能廣東依託其豐富的探鳥雷達技術儲備和完全自主知識產權可控的核心芯片與算法,不斷強化雷達核心技術的自主知識產權研發創新能力,未來芯泰智能廣東計劃在鳥情監控領域進一步發揮所長,在低空監測領域自主研發「機場及主要設施無人機監控系統」,目標實現7*24小時360度全方位探測和反制。
集團亦將持續關注世界前沿技術趨勢,順應航空航天領域發展浪潮,探索及評估新商機和投資項目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.